Biotech company Zealand Pharma A/S, an innovator in peptide-based medicines, announced the positive topline results from its phase 3 trial of glepaglutide on Friday.

Discover heartwarming and uplifting stories with the Good News section on New Indian Express. Stay positive with inspiring news from around the world.

Eli Lilly's gene-silencing drug lepodisiran has been shown to reduce lipoprotein (a) levels by more than 90% for at least six months with a single injection in a phase 2 trial, reinforcing its ...